(3S)-3-(3-(2-cyclopentyl-2-(4-(5-ethylpyridin-3-yl)phenyl)acetamido)-2-methylphenyl)pentanoic acid

ID: ALA4435689

Chembl Id: CHEMBL4435689

PubChem CID: 155511272

Max Phase: Preclinical

Molecular Formula: C32H38N2O3

Molecular Weight: 498.67

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1cncc(-c2ccc(C(C(=O)Nc3cccc([C@@H](CC)CC(=O)O)c3C)C3CCCC3)cc2)c1

Standard InChI:  InChI=1S/C32H38N2O3/c1-4-22-17-27(20-33-19-22)24-13-15-26(16-14-24)31(25-9-6-7-10-25)32(37)34-29-12-8-11-28(21(29)3)23(5-2)18-30(35)36/h8,11-17,19-20,23,25,31H,4-7,9-10,18H2,1-3H3,(H,34,37)(H,35,36)/t23-,31?/m0/s1

Standard InChI Key:  YCZXGDRTZAULOW-YNBNEFOKSA-N

Alternative Forms

  1. Parent:

    ALA4435689

    ---

Associated Targets(Human)

PTGES Tchem Prostaglandin E synthase (3082 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ptges Prostaglandin E synthase (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.67Molecular Weight (Monoisotopic): 498.2882AlogP: 7.50#Rotatable Bonds: 10
Polar Surface Area: 79.29Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.28CX Basic pKa: 5.24CX LogP: 6.51CX LogD: 4.64
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.30Np Likeness Score: -0.60

References

1. Koppitz M, Bräuer N, Ter Laak A, Irlbacher H, Rotgeri A, Coelho AM, Walter D, Steinmeyer A, Zollner TM, Peters M, Nagel J..  (2019)  Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis.,  29  (18): [PMID:31362919] [10.1016/j.bmcl.2019.07.007]

Source